Automated Recovery Line for Medication Assisted Treatment
2 other identifiers
interventional
60
1 country
1
Brief Summary
If shown to be effective, the Recovery Line would provide an inexpensive, transportable, and easy to use treatment to improve substance abuse outcomes for medication assisted treatment. Given the high costs of relapse and continued drug use, improvement of treatment outcomes would provide substantial health, economic, and societal benefits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2014
CompletedFirst Posted
Study publicly available on registry
April 28, 2014
CompletedStudy Start
First participant enrolled
November 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedJuly 2, 2017
June 1, 2017
1.4 years
April 24, 2014
June 28, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
urine screens
bi-weekly urine screens negative for illicit drugs
6 months
self reported drug use
monthly days of self reported illicit drug abstinence
6 months
Secondary Outcomes (2)
treatment retention
6 months
coping behaviors
6 months
Other Outcomes (2)
patient satisfaction
6 months
type and amount of health and psychosocial services
6 months
Study Arms (2)
Recovery Line plus Treatment-as-Usual (RL+TAU)
EXPERIMENTALThe Recovery Line is an automated computer-based IVR system that provides CBT-based modules. The RL+TAU condition will include the customized therapeutic recommendations developed in Phase 1, and the contact reminders messages and time frame that maximized system use in Phase 2. Patients will receive an orientation, 24-hour access, encouragement to use the system from clinic staff reminder, and technical assistance line for system problems. Patients will receive 12 weeks of system access.
Treatment-as-Usual
NO INTERVENTIONTreatment-as Usual involves daily methadone and associated psychosocial services. Patients are required to attend 1 group session per month and are encouraged to attend open drop-in groups available daily covering a range of topics.
Interventions
Eligibility Criteria
You may qualify if:
- are at least 18 years old
- currently receiving methadone maintenance treatment
- illicit drug use in the past 14 days or a positive urine screen for any tested illicit drug.
You may not qualify if:
- Current suicide or homicide risk
- meet criteria for Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV current psychotic disorder, or bipolar disorder
- Unable to read or understand English
- Unable to complete the study because of anticipated incarceration or move
- Life-threatening or unstable medical problems.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- APT Foundation, Inc.collaborator
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
MRU, APT Foundation, Inc
New Haven, Connecticut, 06519, United States
Related Publications (1)
Moore BA, Buono FD, Printz DMB, Lloyd DP, Fiellin DA, Cutter CJ, Schottenfeld RS, Barry DT. Customized recommendations and reminder text messages for automated, computer-based treatment during methadone. Exp Clin Psychopharmacol. 2017 Dec;25(6):485-495. doi: 10.1037/pha0000149.
PMID: 29251978DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2014
First Posted
April 28, 2014
Study Start
November 1, 2015
Primary Completion
April 1, 2017
Study Completion
April 1, 2017
Last Updated
July 2, 2017
Record last verified: 2017-06